CARL ANTHONY BLAU, MD
Osteopathic Medicine at Pacific St, Seattle, WA

License number
Washington MD00026522
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-4100
National Provider ID: 1881779619
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about CARL ANTHONY BLAU at radaris.com
Name
Address
Phone
Carl Blau, age 64
9435 45Th Ave SW, Seattle, WA 98136
(206) 938-0815
Carl A Blau, age 64
5003 119Th Ave SE, Bellevue, WA 98006
(425) 562-2671
(425) 747-7766
Carl A Blau, age 64
601 Mercer Pl, Seattle, WA 98119

Professional information

Carl A Blau Photo 1

Dr. Carl A Blau, Seattle WA - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Seattle Cancer Care Alliance
825 Eastlake Ave E, Seattle 98109
(855) 557-0555 (Phone)
Certifications:
Hematology, 1992, Internal Medicine, 1989, Medical Oncology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English, German
Hospitals:
Seattle Cancer Care Alliance
825 Eastlake Ave E, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
Ohio State University College Of Medicine and Public Health
Graduated: 1986

Carl Anthony Blau Photo 2

Carl Anthony Blau, Seattle WA
Specialties:
Internist
Address:
University Of Washington Medical Ctr, Seattle, WA 98195
Education:
Ohio State University, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)

Carl Blau Photo 3

Quantitative/Semi-Quantitative Measurement Of Epor On Cancer Cells

US Patent:
2010029, Nov 25, 2010
Filed:
Oct 8, 2008
Appl. No.:
12/682105
Inventors:
Christopher P. Miller - Seattle WA, US
Carl Anthony Blau - Seattle WA, US
Michael Henke - Freiberg, DE
Assignee:
UNIVERSITY OF WASHINGTON through its Center for Commercialization - Seattle WA
International Classification:
C12Q 1/68, G01N 33/53, G01N 33/574
US Classification:
435 6, 435 792, 435 723
Abstract:
The present invention provides for assays useful in predicting whether a cancer patient risks suffering erythropoietin-induced tumor progression if treated with erythropoietin. More specifically, one embodiment provides for a validated quantitative reverse transcriptase polymerase chain reaction assay that detects erythropoietin receptor expression, thus indicating whether a cancer patient risks suffering erythropoietin-induced tumor progression if treated with erythropoietin.

Carl Blau Photo 4

Methods Of Controlling Cell Differentiation And Growth Using A Fusion Protein And A Drug

US Patent:
7754202, Jul 13, 2010
Filed:
Jan 7, 1999
Appl. No.:
09/582916
Inventors:
Carl Anthony Blau - Seattle WA, US
David M. Spencer - Houston TX, US
Assignee:
Stanford University - Palo Alto CA
University of Washington - Seattle WA
International Classification:
A61K 48/00, C12N 5/00, C12N 15/63
US Classification:
424 9321, 514 44 R, 435325, 4353201, 435455
Abstract:
This invention involves methods and materials for conferring a direct proliferative advantage on a genetically modified subpopulation of cells. Selection is then accomplished by exerting a positive selective stimulus on the engineered cells rather than a negative pressure on nonengineered cells.

Carl Blau Photo 5

Methods For Treating Cancer

US Patent:
2005023, Oct 27, 2005
Filed:
Apr 7, 2005
Appl. No.:
11/100817
Inventors:
Carl Blau - Seattle WA, US
International Classification:
A61K048/00
US Classification:
424093210
Abstract:
The present invention relates to methods and compositions for treating cancer and related diseases.

Osteopathic Medicine licenses in Washington










Other Doctors licenses in Washington